Methods for assessing the potential health risks of traces of pharmaceuticals in drinking water;Metody hodnocení zdravotních rizik stopových množství léčiv v pitné vodě

Casopis Lekaru Ceskych

Volumn 151, Issue 1, 2012, Pages 5-8

  Kožíšek, František ^a,b   Jeligová, Hana ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Drinking water; Exposure; Human health; Pharmaceuticals; Risk assessment

Indexed keywords

DRINKING WATER; DRUG;

HUMAN; REVIEW; RISK ASSESSMENT; WATER POLLUTANT;

DRINKING WATER; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

EID: 84858136107     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Bound JP, Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ Health Perspect 2005; 113: 1705-1711. (Pubitemid 41794265)
2. Kümmerer K. Pharmaceuticals in the environment: scope of the book and introduction. In: Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Heidelberg: Springer 2004; 3-12.
3. Kožíšek F, Čadek V, Jeligová H. Výskyt humánních léčiv v pitných vodách. SOVAK - Časopis oboru vodovodů a kanalizací 2010; 19(3): 71-75.
4. Webb S, Ternes T, Gibert M, Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 2003; 142: 157-167. (Pubitemid 36412006)
5. WHO. Pharmaceuticals in Drinking-water. WHO/HSE/WSH/ /11.05. World Health Organization, Geneva: 2011; 49 s.
6. DWI. Desk based review of current knowledge on pharmaceuticals in drinking water and estimation of potential levels. Final report prepared by Watts and Crane Associates for Drinking Water Inspectorate, Department for Environment, Food and Rural Affairs, London: 2007 (Defra Project Code: CSA 7184/WT02046/DWI70/2/213; http://dwi.defra.gov.uk/research/ completed-research/ reports/dwi70-2-213.pdf).
7. Schulman LJ, Sargent EV, Naumann BD, et al. A human health risk assessment of pharmaceuticals in the aquatic environment. Hum Ecol Risk Assess 2002; 8: 657-680. (Pubitemid 41002721)
8. Cunningham VL, Binks SP, Olson MJ. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul Toxicol Pharmacol 2009; 53(1): 39-45.
9. Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ, Roden NM, et al. Human pharmaceuticals in US surface water: a human health risk assessment. Regul Toxicol Pharmacol 2005; 42(3): 296-312. (Pubitemid 41021979)
10. NRMMC, EPHC, NHMRC. Australian guidelines for water recycling: managing health and environmental risks (PHASE 2). Augmentation of drinking water supplies. Natural Resource Management Ministerial Council, Environment Protection and Heritage Council and National Health and Medical Research Council 2008 (http://www.qwc.qld.gov.au/prw/pdf/agwr-augmen tation-drinkingwater- supplies-08-05.pdf).
11. Snyder SA, Trenholm RA, Snyder EM, Bruce GM, Pleus RC. Toxicological relevance of EDCs and pharmaceuticals in drinking water. AwwaRF Project 3085. Denver: Awwa Research Foundation 2008.
12. Travis KZ, Pate I,Welsh ZK. The role of the benchmark dose in a regulatory context. Regul Toxicol Pharmacol 2005; 43: 280-291. (Pubitemid 41616394)
13. Dieter HH, Mückter H. Regulatorische, gesundheitliche und ästhetische Bewertung sogenannter Spurenstoffe im Trinkwasser unter besonderer Berücksichtigung von Arzneimitteln. Bundesgesundheitsbl- Gesundheitsforsch-Gesundheitsschutz 2007; 50: 322-331.
14. Kümmerer K, Al-Ahmad A. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water. Environ Sci Pollut Res 2010; 17: 486-496.
15. Cramer GM, Ford RA, Hall RL. Estimation of toxic hazard - a decision tree approach. Food Chem Toxicol 1978; 16: 255-276. (Pubitemid 9010193)
16. Munro IC, Ford RA, Kennepohl E, Sprenger JG. Correlation of structural class with no-observed effect levels: a proposal for establishing a threshold of concern. Food Chem Toxicol 1996; 34: 829-867. (Pubitemid 26420127)
17. Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, et al. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol 2004; 42(1): 65-83. (Pubitemid 37421327)
18. Caldwell DJ, Mastrocco F, Nowak E, Johnston J,Yekel H, et al. An assessment of potential exposure and risk from estrogens in drinking water. Environ Health Perspect 2010; 118(3): 338-344.
19. Stanford BD, Trenholm RA, Holady JC, Vanderford BJ, Snyder SA. Estrogenic activity of US drinking waters: A relative exposure comparison. Journal AWWA 2010; 102(11): 55-65.
20. Christensen FM. Pharmaceuticals in the environment - a human risk? Regul Toxicol Pharmacol 1998; 28: 212-221. (Pubitemid 29096162)
21. Bewertung der Anwesenheit teil- oder nicht bewertbarer Stoffe im Trinkwasser aus gesundheitlicher Sicht. Empfehlung des Umweltbundesamtes nach Anhörung der Trinkwasserkommission beim Umweltbundesamt. Bundesgesundhbl- Gesundheitsforsch-Gesundheitsschutz 2003; 45: 249-251.
22. Pomati F, Orlandi Ch, Clerici M, Luciani F, Zuccato E. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 2008; 102: 129-137. (Pubitemid 351250475)